
### [NCIT:C7541](http://purl.obolibrary.org/obo/NCIT_C7541)
**Label:** Retinoblastoma

**Subclasses:** [NCIT:C7846](http://purl.obolibrary.org/obo/NCIT_C7846) (Intraocular Retinoblastoma), [NCIT:C7849](http://purl.obolibrary.org/obo/NCIT_C7849) (Recurrent Retinoblastoma), [NCIT:C7848](http://purl.obolibrary.org/obo/NCIT_C7848) (Extraocular Retinoblastoma), [NCIT:C8713](http://purl.obolibrary.org/obo/NCIT_C8713) (Bilateral Retinoblastoma), [NCIT:C8714](http://purl.obolibrary.org/obo/NCIT_C8714) (Unilateral Retinoblastoma), [NCIT:C7019](http://purl.obolibrary.org/obo/NCIT_C7019) (Trilateral Retinoblastoma), [NCIT:C9048](http://purl.obolibrary.org/obo/NCIT_C9048) (Childhood Extraocular Retinoblastoma), [NCIT:C66813](http://purl.obolibrary.org/obo/NCIT_C66813) (Differentiated Retinoblastoma), [NCIT:C9047](http://purl.obolibrary.org/obo/NCIT_C9047) (Childhood Intraocular Retinoblastoma), [NCIT:C66815](http://purl.obolibrary.org/obo/NCIT_C66815) (Diffuse Retinoblastoma), [NCIT:C8495](http://purl.obolibrary.org/obo/NCIT_C8495) (Hereditary Retinoblastoma), [NCIT:C66814](http://purl.obolibrary.org/obo/NCIT_C66814) (Undifferentiated Retinoblastoma), [NCIT:C42596](http://purl.obolibrary.org/obo/NCIT_C42596) (Sporadic Retinoblastoma), 

**Class expressions from DL-Learner:**

- Thing 54.38%
- [NCIT:C9344](http://purl.obolibrary.org/obo/NCIT_C9344) (Pineoblastoma) 51.72%
- [NCIT:C4817](http://purl.obolibrary.org/obo/NCIT_C4817) (Ewing Sarcoma) 51.72%
- [NCIT:C27291](http://purl.obolibrary.org/obo/NCIT_C27291) (Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor) and [NCIT:C9118](http://purl.obolibrary.org/obo/NCIT_C9118) (Sarcoma) 51.72%
- [NCIT:C27291](http://purl.obolibrary.org/obo/NCIT_C27291) (Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor) and [NCIT:C3810](http://purl.obolibrary.org/obo/NCIT_C3810) (Connective and Soft Tissue Neoplasm) 51.72%
- [NCIT:C27291](http://purl.obolibrary.org/obo/NCIT_C27291) (Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor) and [NCIT:C3263](http://purl.obolibrary.org/obo/NCIT_C3263) (Neoplasm by Site) 51.72%
- [NCIT:C27291](http://purl.obolibrary.org/obo/NCIT_C27291) (Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor) and [NCIT:C27574](http://purl.obolibrary.org/obo/NCIT_C27574) (Connective and Soft Tissue Disorder) 51.72%
- [NCIT:C27291](http://purl.obolibrary.org/obo/NCIT_C27291) (Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor) and [NCIT:C27551](http://purl.obolibrary.org/obo/NCIT_C27551) (Disorder by Site) 51.72%
- [NCIT:C27291](http://purl.obolibrary.org/obo/NCIT_C27291) (Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor) and [NCIT:C27574](http://purl.obolibrary.org/obo/NCIT_C27574) (Connective and Soft Tissue Disorder) and [NCIT:C3263](http://purl.obolibrary.org/obo/NCIT_C3263) (Neoplasm by Site) 51.72%
- [NCIT:C27291](http://purl.obolibrary.org/obo/NCIT_C27291) (Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor) and [NCIT:C27551](http://purl.obolibrary.org/obo/NCIT_C27551) (Disorder by Site) and [NCIT:C3263](http://purl.obolibrary.org/obo/NCIT_C3263) (Neoplasm by Site) 51.72%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 42.42%
- [NCIT:C27291](http://purl.obolibrary.org/obo/NCIT_C27291) (Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor) 37.08%
- [NCIT:C27291](http://purl.obolibrary.org/obo/NCIT_C27291) (Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor) and (not ([NCIT:C35853](http://purl.obolibrary.org/obo/NCIT_C35853) (Grade 3 Clear Cell Renal Cell Carcinoma))) 37.08%
- [NCIT:C27291](http://purl.obolibrary.org/obo/NCIT_C27291) (Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor) and (not ([NCIT:C35852](http://purl.obolibrary.org/obo/NCIT_C35852) (Grade 2 Clear Cell Renal Cell Carcinoma))) 37.08%
- [NCIT:C27291](http://purl.obolibrary.org/obo/NCIT_C27291) (Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor) and (not ([NCIT:C35851](http://purl.obolibrary.org/obo/NCIT_C35851) (Grade 1 Clear Cell Renal Cell Carcinoma))) 37.08%


